Benchmark_logo.jpg
The Benchmark Company Announces “Healthcare House Call” Upcoming Virtual 1x1 Investor Conference
June 11, 2020 16:34 ET | The Benchmark Company
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company is pleased to announce our upcoming Virtual 1x1 “Healthcare House Call” Investor Conference June 15-16th.  The conference features...
Benchmark_logo.jpg
The Benchmark Company Announces Closing of Public Offering of $5.0 Million for Hoth Therapeutics, Inc.
May 28, 2020 10:02 ET | The Benchmark Company
NEW YORK, May 28, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company announced the closing on March 27th of an Underwritten Public Offering for Hoth Therapeutics, Inc. (NASDAQ: HOTH) of 1,818,182 shares...
Benchmark_logo.jpg
The Benchmark Company Expands Its Biotechnology Focus With The Addition Of Dr. Aydin Huseynov And Dr. Okechukwu Linton
February 26, 2020 09:00 ET | The Benchmark Company, Llc
NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, an institutionally focused research, sales & trading, and investment banking firm covering multiple sectors, including...
Benchmark_logo.jpg
The Benchmark Company Announces Closing of Public Offering of $5m for Seelos Therapeutics, Inc.
February 13, 2020 15:51 ET | The Benchmark Company, Llc
NEW YORK, Feb. 13, 2020 (GLOBE NEWSWIRE) -- The Benchmark Company today announced the closing of an Underwritten Public Offering for Seelos Therapeutics, Inc. of 6,666,667 shares of common stock at...
Benchmark_logo.jpg
Edward Rubin Joins the Benchmark Company as Co-Head of Investment Banking
December 02, 2019 09:37 ET | The Benchmark Company, Llc
NEW YORK, Dec. 02, 2019 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC, a leading investment bank focused on capital markets, equity research and sales & trading for emerging and growth...
Benchmark_logo.jpg
The Benchmark Company, LLC Announces Closing of Initial Public Offering of CNS Pharmaceuticals, Inc.
November 13, 2019 16:30 ET | The Benchmark Company, Llc
NEW YORK, Nov. 13, 2019 (GLOBE NEWSWIRE) -- The Benchmark Company, LLC today announced the closing of an Initial Public Offering for CNS Pharmaceuticals, Inc. of 2,125,000 shares of common stock at...